The use of second-trimester genetic sonogram in guiding clinical management of patients at increased risk for fetal trisomy 21

Obstetrics and Gynecology

Volumn 87, Issue 6, 1996, Pages 948-952

  Vintzileos, Anthony M ^a   Campbell, Winston A ^b   Rodis, John F ^b   Guzman, Edwin R ^b   Smulian, John C ^b   Knuppel, Robert A ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMNIOCENTESIS; ANATOMY; ANEUPLOIDY; ARTICLE; BIOMETRY; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; ECHOGRAPHY; FEMALE; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; TRISOMY 21;

EID: 0029950690     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00053-1     Document Type: Article

References (20)

1. Nyberg DA, Resta RG, Luthy DA, Hickok DE, Mahony BS, Hirsch JH. Prenatal sonographic findings of Down syndrome: Review of 94 cases. Obstet Gynecol 1990;76:370-7.
2. Benacerraf BR, Neuberg D, Bromley B, Frigoletto FD. Sonographic scoring index for prenatal detection of chromosomal abnormalities. J Ultrasound Med 1992;11:449-58.
3. Lockwood C, Benacerraf B, Krinsky A, Blakemore K, Belanger K, Mahoney M, et al. A sonographic screening method for Down syndrome. Am J Obstet Gynecol 1987;157:803-8.
4. Perrella R, Duerinck AJ, Grant EG, Tessler F, Tabsh K, Crandall BF. Second-trimester sonographic diagnosis of Down syndrome: Role of femur-length shortening and nuchal-fold thickening. AJR 1988; 151:981-5.
5. Dicke JM, Gray DL, Songster GS, Crane JP. Fetal biometry as a screening tool for the detection of chromosomally abnormal pregnancies. Obstet Gynecol 1989;74:726-9.
6. Rodis JF, Vintzileos AM, Fleming AD, Ciarleglio L, Nardi DA, Feeney L, et al. Comparison of humerus length versus femur length in fetuses with Down syndrome. Am J Obstet Gynecol 1991;164:1051-6.
7. Rotmensch S, Luo JS, Liberati M, Belanger K, Mahoney MJ, Hobbins JC. Fetal humeral length to detect Down syndrome. Am J Obstet Gynecol 1992;166:1330-4.
8. Nyberg DA, Resta RG, Luthy DA, Hickok DE, Williams MA. Humerus and femur length shortening in the detection of Down's syndrome. Am J Obstet Gynecol 1993;168:534-8.
9. Benacerraf BR, Mandell J, Estroff JA, Harlow BL, Frigoletto FD. Fetal pyelectasis: A possible association with Down syndrome. Obstet Gynecol 1990;76:58-60.
10. Corteville JE, Dicke JM, Crane JP. Fetal pyelectasis and Down syndrome: Is genetic amniocentesis warranted? Obstet Gynecol 1992;79:770-2.
11. Benacerraf BR, Frigoletto FD. Soft tissue nuchal fold in the second-trimester fetus: Standards for normal measurements compared with those in Down syndrome. Am J Obstet Gynecol 1987;157: 1146-9.
12. Crane JP, Gray DL. Sonographically measured nuchal skinfold thickness as a screening tool for Down syndrome: Results of a prospective clinical trial. Obstet Gynecol 1991;77:533-6.
13. Scioscia AL, Pretorius DH, Budorick NE, Cahill TC, Axelrod FT, Leopold GR. Second trimester echogenic bowel and chromosomal abnormalities. Am J Obstet Gynecol 1992;167:889-94.
14. Dicke JM, Crane JP. Sonographically detected hyperechoic fetal bowel: Significance and implications for pregnancy management. Obstet Gynecol 1992;80:778-82.
15. Benacerraf BR, Harlow BL, Frigoletto FD. Hypoplasia of the middle phalanx of the fifth digit. J Ultrasound Med 1990;9:389-94.
16. Nadel AS, Bromley B, Frigoletto FD, Benacerraf BR. Can the presumed risk of autosomal trisomy be decreased in fetuses of older women following a normal sonogram? J Ultrasound Med 1995;14:297-302.
17. Nyberg DA, Luthy DA, Cheng EY, Sheley RC, Resta RG, Williams MA. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers. Am J Obstet Gynecol 1995;173:1030-5.
18. DeVore GR, Alfi O. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: An alternative for high-risk patients who decline genetic amniocentesis. Obstet Gynecol 1995; 85:378-86.
19. Vintzileos AM, Egan JFX. Adjusting the risk for trisomy 21 on the basis of second trimester ultrasonography. Am J Obstet Gynecol 1995;172:837-44.
20. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 1994;330:114-8.